1. Market Research
  2. > Accera, Inc. – Product Pipeline Review – 2013

Accera, Inc. – Product Pipeline Review – 2013

  • May 2013
  • -
  • Global Markets Direct
  • -
  • 25 pages

Accera, Inc. – Product Pipeline Review – 2013

Summary

Global Market Direct’s pharmaceuticals report, “Accera, Inc. - Product Pipeline Review - 2013” provides data on the Accera, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Accera, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Accera, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Accera, Inc. - Brief Accera, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Accera, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Accera, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Accera, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Accera, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Accera, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Accera, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Accera, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Accera, Inc. and identify potential opportunities in those areas.

Table Of Contents

Accera, Inc. - Product Pipeline Review - 2013
Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
Accera, Inc. Snapshot 4
Accera, Inc. Overview 4
Key Information 4
Key Facts 4
Accera, Inc. - Research and Development Overview 5
Key Therapeutic Areas 5
Accera, Inc. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Accera, Inc. - Pipeline Products Glance 9
Accera, Inc. - Early Stage Pipeline Products 9
Pre-Clinical Products/Combination Treatment Modalities 9
Accera, Inc. - Drug Profiles 10
AC-0523 10
Product Description 10
Mechanism of Action 10
RandD Progress 10
AC-8632 11
Product Description 11
Mechanism of Action 11
RandD Progress 11
Accera, Inc. - Pipeline Products By Mechanism of Action 12
Accera, Inc. - Recent Pipeline Updates 13
Accera, Inc. - Locations And Subsidiaries 14
Head Office 14
Accera, Inc., Recent Developments 15
Accera, Inc.- Press Release 15
Apr 09, 2013: Accera And University of Miami Collaborate To Study Axona For Cognitive Impairment In Patients With Multiple Sclerosis 15
Oct 05, 2010: Accera Receives FDA Acceptance Of IND Application For AC-1204 For Alzheimer's Disease 15
Mar 10, 2010: Accera Announces New Data On Ketone Body Therapy For Alzheimer's Disease Treatment 16
Financial Deals Landscape 18
Accera, Inc., Deals Summary 18
Accera, Inc., Pharmaceuticals and Healthcare, Deal Details 19
Venture Financing 19
Accera Raises Additional US$15 Million In Venture Financing 19
Accera Secures US$11 Million In Venture Financing 20
Accera Secures US$35 Million In Series C Financing 21
Acquisition 22
Nestle Health Science Completes Acquisition Of Minority Stake In Accera 22
Appendix 24
Methodology 24
Coverage 24
Secondary Research 24
Primary Research 24
Expert Panel Validation 24
Contact Us 25
Disclaimer 25



List of Tables

Accera, Inc., Key Information 4
Accera, Inc., Key Facts 4
Accera, Inc. - Pipeline by Indication, 2013 6
Accera, Inc. - Pipeline by Stage of Development, 2013 7
Accera, Inc. - Monotherapy Products in Pipeline, 2013 8
Accera, Inc. - Pre-Clinical, 2013 9
Accera, Inc. - Pipeline Products By Mechanism of Action, 2013 12
Accera, Inc. - Recent Pipeline Updates, 2013 13
Accera, Inc., Deals Summary 18
Accera Raises Additional US$15 Million In Venture Financing 19
Accera Secures US$11 Million In Venture Financing 20
Accera Secures US$35 Million In Series C Financing 21
Nestle Health Science Completes Acquisition Of Minority Stake In Accera 22



List of Figures

Accera, Inc. - Pipeline by Indication, 2013 6
Accera, Inc. - Pipeline by Stage of Development, 2013 7
Accera, Inc. - Monotherapy Products in Pipeline, 2013 8

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.